BofA raised the firm’s price target on Encompass Health (EHC) to $160 from $145 and keeps a Buy rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- Encompass Health management to meet virtually with KeyBanc
- Encompass Health, BSA Health System announce joint venture
- Encompass Health price target raised to $140 from $135 at Truist
- Encompass Health to build 50-bed inpatient rehabilitation hospital in Texas
- Encompass Health: Strong Financial Performance and Growth Potential Drive Buy Rating